![Sunil Rao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Sunil Rao
Entité | Type d'entité | Industrie | |
---|---|---|---|
Armed Forces Medical College
1
| College/University | Other Consumer Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Sunil Rao via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
GILEAD SCIENCES, INC. | Biotechnology | President | |
Samsara Biocapital LLC
![]() Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Celera Corp.
![]() Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
University of Michigan | College/University | Graduate Degree | |
OrsoBio Inc
![]() OrsoBio Inc Miscellaneous Commercial ServicesCommercial Services Orsobio, Inc. is a clinical-stage biopharmaceutical company that focuses on developing therapies to treat obesity and other severe metabolic disorders, such as type 2 diabetes, NASH, and severe dyslipidemias. The company is based in Palo Alto, CA. The company has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism. Orsobio has a team of physicians and scientists who are dedicated to developing therapies to treat organ failure in patients with severe metabolic disorders. The company was founded by Mani Subramanian, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 7 |
Sectorielle
Health Technology | 3 |
Finance | 2 |
Health Services | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Opérationnelle
Director/Board Member | 2 |
President | 1 |
Private Equity Investor | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Relations les plus connectées
Insiders | |
---|---|
Mani Subramanian | 7 |